Profil
Mike Holfinger worked as Vice President of Manufacturing at Alexza Pharmaceuticals, Inc. from 2013 to 2015.
Prior to that, he held the same position at Affymax, Inc. from 2006 to 2013.
He also worked as Vice President of Manufacturing and Supply Chain at Aimmune Therapeutics, Inc. Dr. Holfinger received an undergraduate degree from Miami University and a doctorate degree from the University of Wisconsin.
Ehemalige bekannte Positionen von Mike Holfinger
| Unternehmen | Position | Ende |
|---|---|---|
| ALEXZA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.06.2013 |
| AFFYMAX, INC. | Corporate Officer/Principal | 01.06.2013 |
| AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Mike Holfinger
| University of Wisconsin | Doctorate Degree |
| Miami University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
